NAYA Biosciences Operating Income 2010-2024 | IVF
NAYA Biosciences operating income from 2010 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
NAYA Biosciences Annual Operating Income
(Millions of US $) |
| 2024 |
$-8 |
| 2023 |
$-7 |
| 2022 |
$-11 |
| 2021 |
$-5 |
| 2020 |
$-6 |
| 2019 |
$-2 |
| 2018 |
$-3 |
| 2017 |
$-1 |
| 2016 |
$-2 |
| 2015 |
$-1 |
| 2014 |
$-2 |
| 2013 |
$-1 |
| 2012 |
$-1 |
| 2011 |
$-1 |
| 2010 |
$-2 |
| 2009 |
$-2 |
NAYA Biosciences Quarterly Operating Income
(Millions of US $) |
| 2024-12-31 |
$-4 |
| 2024-09-30 |
$-1 |
| 2024-06-30 |
$-2 |
| 2024-03-31 |
$-1 |
| 2023-12-31 |
$-2 |
| 2023-09-30 |
$-1 |
| 2023-06-30 |
$-2 |
| 2023-03-31 |
$-2 |
| 2022-12-31 |
$-3 |
| 2022-09-30 |
$-3 |
| 2022-06-30 |
$-3 |
| 2022-03-31 |
$-3 |
| 2021-12-31 |
$1 |
| 2021-09-30 |
$-2 |
| 2021-06-30 |
$-2 |
| 2021-03-31 |
$-2 |
| 2020-12-31 |
$-2 |
| 2020-09-30 |
$-1 |
| 2020-06-30 |
$-1 |
| 2020-03-31 |
$-1 |
| 2019-12-31 |
$-1 |
| 2019-09-30 |
$-1 |
| 2019-06-30 |
$0 |
| 2019-03-31 |
$0 |
| 2018-12-31 |
$-1 |
| 2018-09-30 |
$0 |
| 2018-06-30 |
$-2 |
| 2018-03-31 |
$0 |
| 2017-12-31 |
$0 |
| 2017-09-30 |
$0 |
| 2017-06-30 |
$0 |
| 2017-03-31 |
$0 |
| 2016-12-31 |
$0 |
| 2016-09-30 |
$0 |
| 2016-06-30 |
$-1 |
| 2016-03-31 |
$0 |
| 2015-12-31 |
$0 |
| 2015-09-30 |
$0 |
| 2015-06-30 |
$0 |
| 2015-03-31 |
$0 |
| 2011-12-31 |
$0 |
| 2011-09-30 |
$0 |
| 2011-06-30 |
$0 |
| 2011-03-31 |
$0 |
| 2010-12-31 |
$0 |
| 2010-09-30 |
$0 |
| 2010-06-30 |
$0 |
| 2010-03-31 |
$0 |
| 2009-12-31 |
$0 |
| 2009-09-30 |
$0 |
| 2009-06-30 |
$0 |
| 2009-03-31 |
$-1 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.001B |
$0.007B |
|
NAYA Biosciences is a life science portfolio company dedicated to bringing breakthrough treatments to patients in oncology, autoimmune diseases and fertility. NAYA Biosciences, formerly known as INVO BIOSCIENCE, is based in SARASOTA, Fla.
|
